Beatrice Claudia Cianciotti

Author

Vita-Salute San Raffaele University ORCID

Also Known As

Beatrice C. Cianciotti, Beatrice Cianciotti, Beatrice Claudia Cianciotti

Publications

448

Citations

H-Index

Concepts

All Affiliations

Vita-Salute San Raffaele University Humanitas University IRCCS Humanitas Research Hospital IRCCS Ospedale San Raffaele Istituti di Ricovero e Cura a Carattere Scientifico

About

Beatrice Claudia Cianciotti is an author at Vita-Salute San Raffaele University.

Beatrice Claudia Cianciotti

Publications

340

Citations

H-Index

Page 1

	Year	Citations
Generation of human memory stem T cells after haploidentical T-replete hematopoietic stem cell transplantation Nicoletta Cieri, Giacomo Oliveira, Raffaella Greco, Blood	2015	132
CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function Eliana Ruggiero, Erica Carnevale, Aaron Prodeus, Science Translational Medicine	2022	44
CD4+ Memory Stem T Cells Recognizing Citrullinated Epitopes Are Expanded in Patients With Rheumatoid Arthritis and Sensitive to Tumor Necrosis Factor Blockade Beatrice Claudia Cianciotti, Eliana Ruggiero, Corrado Campochiaro, Arthritis & Rheumatology	2019	42
Tailored chemokine receptor modification improves homing of adoptive therapy T cells in a spontaneous tumor model Stefano Garetto, Claudia Sardi, Elisa Martini, Oncotarget	2016	34
Revealing and harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells Alessia Potenza, Chiara Balestrieri, Martina Spiga, Gut	2023	25
TIM-3, LAG-3, or 2B4 gene disruptions increase the anti-tumor response of engineered T cells Beatrice Claudia Cianciotti, Zulma Magnani, Alessia Ugolini, Frontiers in Immunology	2024	20
Flow cytometry data mining by cytoChain identifies determinants of exhaustion and stemness in TCR‐engineered T cells Francesco Manfredi, Danilo Abbati, Beatrice Claudia Cianciotti, European Journal of Immunology	2021	15
Regulatory T cell depletion promotes myeloid cell activation and glioblastoma response to anti-PD1 and tumor-targeting antibodies Felipe Gálvez‐Cancino, Mariela Navarrete, Gordon Beattie, Immunity	2025	15
T Cell Features in Glioblastoma May Guide Therapeutic Strategies to Overcome Microenvironment Immunosuppression Agnese Losurdo, Antonio Di Muzio, Beatrice Claudia Cianciotti, Cancers	2024	13

Page 1